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ABSTRACT 
 
Background: Cervical cancer is the second highest cause of cancer related death worldwide, the highest in Africa 
and also the most frequent cancer in Zambian women. The incidence is high in human immunodeficiency virus 
positive (HIV+) patient as established by some sources. Objectives: The objectives of the study were to determine 
the association of HIV infection and other risk factors to cervical cancer. Method: The study was a cross sectional 
retrospective study done at Ndola central hospital in Zambia. A sample size of 172 was made up of 86 confirmed 
cases of cervical cancer and 86 suspected cases of cervical cancer. The statistical tests used in the analysis of the 
data were the chi square and regression bivariate logistical model. The level of significance was 0.05.Results: No 
significant relation was observed between HIV status and cervical cancer (AOR=1.00; 95% CI [0.71, 1.42]). 
Compared with the individuals aged 45 years or older, those aged less than 35 years were 62% 
(AOR=0.38;95%CI(0.22,0.67)) less likely to have cervical cancer.Conclusion: There is no association between HIV 
infection and cervical cancer in the years 2013 and 2014. There was an association between age and cervical cancer. 
There was an association between being on HAART and cervical cancer hence we conclude that HAART. 
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Introduction 
Cervical cancer is the second leading cause of cancer 
mortality in women worldwide, and the leading cause 
in Africa, and it is the leading cause of cancer deaths in 
Zambianwomen.[1, 2] There is uncertainty in the role 
of HIV infection as a risk factor for invasive and pre-
invasive cervical lesions, particularly in African 
populations.[1] In a case control study in Dakar, 
Senegal,150 women with invasive cervical cancer were 
(ICC), 92 with cervical intraepithelial neoplasia (CIN) 
2 or 3, 70 with CIN 1, and 515 control women 
(1).Logistic regression analysis to estimate associations 
between HIV-1 and HIV-2 infection and the risk of 
cervical neoplasia was used.[1,3]. Large increase in the 
risk of ICC and CIN 2-3 was found, but not of CIN 1,  
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associated with the presence of either HIV-1 or HIV-2 
infection.[1]. The analysis thus shows increases in the 
risk of both advanced and early cervical pathology 
associated with HIV infection in an African population 
[1].  
In sub-Saharan Africa, age-standardized incidence of 
cervical cancer is high, ranging from 29.3 (West 
Africa) to 42.7 (southern Africa) per 100,000 women 
[4]. The development of cervical cancer is the result of 
interaction of systemic and local cofactors that 
facilitate malignant transformation of cervical cells, 
with HPV infection as a necessary factor [4]. Based on 
strength of association with cervical cancer, genital 
HPVs have been categorized by risk of acting as 
carcinogens in the development of cervical cancers 
[4,5]. High-risk or oncogenic types include HPV types 
16, 18, 31, 33, 35, 39,41, 45, 51, 52, 56, 58, 59, 66, 68, 
73 and 82; low-risk types include HPV types 6, 11, 42, 
43, 44, 54, 61, 70, 72, 81.[5] Examples of factors other 
than HPV that have been suggested as potential 
modulators of cervical cancer development include age 
and parity , cigarette smoking , long-term oral 
contraceptive use , and host genetics and 
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immunological factors. The incidence of cervical 
cancer has been changing at a global level, with 
increasing incidence in women below 40 years of 
age[3,4]. This may reflect age-cohort effects and the 
emergence of more aggressive histologies with a 
shorter natural history, possibly the result of HPV 
infection acquired at a younger age or of increased 
screening/awareness resulting in earlier detection of 
cervical cancer [1,3]. In HIV-infected women, there is 
an increased risk of HPV infection and squamous 
intraepithelial lesions (SIL), the precursor of cervical 
cancer.[6] Since 1993, the revised CDC AIDS case 
definition has included the development of cervical 
cancer in an HIV-infected person as a sufficient 
criterion for AIDS, even in the absence of an 
opportunistic infection.[7] Numerous studies have 
analyzed the association of HIV infection and cervical 
cancer[7]. Although positive associations between HIV 
infection and cervical cancer have been demonstrated, 
studies evaluating the strength of this association 
among African women have had differing conclusions. 
[5] It has been proposed that lack of excess risk of 
invasive cervical cancer among HIV-infected women 
in some populations may reflect the competing risk of 
mortality from other conditions associated with HIV 
infection.[1] Dr Mulindi Mwanahamuntu at university 
teaching hospital in Lusaka demonstrated that there is a 
strong relationship between the HIV status and the 
cervical cancer both pre and advanced disease as 
compared to those who were  HIV non-reactive of 
above 50%,this prompted the Zambian government to 
come up with cervical cancer prevention program.[8] 
Although many women harbor HPV only a few 
develop invasive carcinoma of the cervix ,meaning 
other risk factors are involved ,well defined ones are 
cigarette smoking and immunodeficiency(HIV increase 
by five ford)[6]. 
The pie chart below shows the conclusion of the report 
from Mulindi Mwanahamuntu and his associates at 
university teaching hospital.[9] 
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Studies of HIV infection and invasive cervical cancer 
to date have tended to be limited by lack of information 
on presence of HPV DNA in cervical samples of study 
participants, and focused on quantifying the effect of 
HIV infection relative to other cofactors in the 
presence of HPV infection (5).A case-control study in a 
West African population to assess the relationship 
between cervical cancer and HIV infection, taking into 
account the presence of high-risk HPV infection and 
other cofactors such as age, parity, and lifetime number 
of sexual partners[10]. 
Method 
The study was a hospital based study involving the 
review of hospital records from the year 2013 to 2014. 
It was cross sectional retrospective study. The files 
were reviewed from 7
th
 may to 14
th
 may 2016 
Study site 
The study was carried out at Ndola central hospital 
which is the second largest referral hospital in Zambia, 
on the coperbelt province within Ndola city the 
provincial capital. 
 
Sampling method  
The sample was selected by getting all the known cases 
of cervical cancer, or those who were suspected cases, 
some which were on palliative care.86 cases were 
known cases of cervical cancer and 86 controls. The 
controls were those who had suspected invasive cell 
carcinoma from cervical cancer screening and those 
cases who were suspected but were non confirmatory 
of cervical cancer. 
The inclusion criteria was that only files of patients 
who were on palliative care , the suspected cases, and 
those with queried invasive cervical carcinoma from 
the cervical cancer screening clinic, were reviewed 
from the year 2013 and 2014. The exclusion criteria 
was as follows: exclude all incomplete records, missing 
files, all files out of the stipulated period of study and 
all files without the age of patients on them. 
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Data Capturing Tool, Data Entry Method and 
Analysis 
The data collection tool had patients age, marital status, 
confirmed cervical cancer (by histopathology or pap 
smear), HIV status, on HAART, and Age at sex debut. 
The data that was captured was entered in the 
Microsoft access then transferred to Microsoft excel, 
and then the data was transferred to the spss software 
16.0 for analysis. The data was analyzed by the spss 
software using the chi square test to associate HIV 
status and other risk factors with cervical cancer.  
 
 
Results 
 
Table 1: Risk factors associated with cervical cancer 
 
Factor Cervical Cancer 
confirmed 
Yes                  No 
n (%)              n(%) 
  
 
P value 
A. Age(years) 
<35 
35-44                                
45+ 
B. Marital status 
Married 
Not married 
 
12(14.3)        29(34.5) 
42(50.0)       35(41.7) 
30(35.7)       20(23.8) 
 
81(93.1)       81(96.4) 
6(6.9)           3(3.6) 
  
 
0.008 
 
 
0.497 
 
 
 
C.HIV status 
Positive 
Negative 
 
33(41.2)        27(36.0) 
47(58.8)       48(64.0) 
 
 
 
 
0.502 
D.ON HAART 
Yes 
No 
 
 
33(37.9)        20(23.8) 
54(62.1)        64(76.2) 
 
  
0.046 
    
Of the factors in table 1.0 only age (p value=0.008) and an HAART (p value=0.046) has the significant association 
with cervical cancer. No significant association between HIV infection (p value=0.502) and cervical cancer were 
observed. 
 
Table 2: Association between HIV status and cervical cancer adjusted for age 
 
Factor Adjusted odd ratio(95%CI) 
Age  
<35 0.32(0.22,0.67) 
35-44 1.35(0.86,2.12) 
45+ 1 
HIV status  
positive 1.00(0.71,1.42) 
negative 1 
 
All the factors that were significantly associated with cervical cancer in bivariate analysis were considered in a 
multivariate logistic regression model that included HIV status. The relationship between HIV status after adjusting 
for age in table 2.0, No significant relation was observed between HIV status and cervical cancer (AOR=1.00; 95% 
CI (0.71, 1.42)). Compared with the individuals aged 45 years or older ,those aged less than 35 years were 62% 
(AOR=0.38;95%CI(0.22,0.67)) less likely to have cervical cancer 
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Discussion 
   
To our knowledge this study is the first one of its kind to 
be done at Ndola central hospital in Zambia. The other 
study on cervical cancer and HIV was done at the 
university teaching hospital in Lusaka, Zambia and it 
showed that there was a significant association between 
cervical cancer and HIV infection [9]. However, our study 
did not find the association between HIV infection and 
cervical cancer. Therefore, this finding indicated that for 
the years 2013 and 2014, there was no association 
between HIV infection and cervical cancer at Ndola 
central hospital. All the factors that were significantly 
associated with cervical cancer in bivariate analysis were 
considered in a multivariate logistic regression model that 
included HIV status. However, only age and having been 
on HAART were found to be significantly associated with 
cervical cancer. Therefore, the finding that HIV is related 
to HIV still stands as can be found in many other studies. 
This is because patients who are on HAART are HIV 
positive. The possible explanation to this finding is that 
HAART makes HIV positive patients less likely to 
develop cervical cancer. Compared with the individuals 
aged 45 years and older, those aged 35years and less were 
less likely to have cervical cancer. This finding is in 
accord with a number of studies that indicate that women 
over 40 remain at risk and need to continue having regular 
cervical cancer screenings, which include both a pap test 
and HPV test. 
  
Limitations 
In our study which was a retrospective study some files 
did not contain some risk factors which were contained in 
other files, however they were considered for inclusion in 
the study. 
Conclusion 
In conclusion, there was no association between HIV 
infection and cervical cancer in the years 2013 and 2014. 
There was an association between age and cervical cancer. 
There was an association between being on HAART and 
cervical cancer hence we conclude that HAART reduces 
the chance of developing cervical cancer. We fail to reject 
the null hypothesis therefore there is no relationship 
between HIV infection and cervical cancer 
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